Glenmark Lobs Counterclaims At Teva In Coreg Suit
Glenmark Pharmaceuticals Ltd. has moved into an offensive position in a patent spat over the preparation of a generic version of congestive heart failure treatment Coreg, accusing Teva Pharmaceuticals Industries Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article